Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, Massachusetts
- Most recent report
- 10-Q, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 510 filings
- On EDGAR
- CIK 1689548
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 24
News 8 of 90
Prospectuses and Registrations 8 of 34
- S-8 Registration statement for an employee plan Feb 19, 2026
- 424B5 Prospectus supplement for an offering Jan 7, 2026
- 424B5 Prospectus supplement for an offering Jan 6, 2026
- 424B5 Prospectus supplement for an offering Oct 20, 2025
- 424B5 Prospectus supplement for an offering Oct 16, 2025
- 424B5 Prospectus supplement for an offering Sep 5, 2025
- S-8 Registration statement for an employee plan Feb 28, 2025
- S-8 Registration statement for an employee plan Feb 28, 2025
Proxies 8 of 16
- DEFA14A Extra proxy material Apr 30, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- DEFA14A Extra proxy material Apr 30, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Oct 16, 2023
- PRE 14A Preliminary proxy statement Oct 4, 2023
Ownership 8 of 316
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Jul 8, 2026
- 4 Insider reported a trade Jun 26, 2026
- 144 Notice of a proposed sale of restricted stock Jun 24, 2026
- 4 Insider reported a trade Jun 12, 2026
- 4 Insider reported a trade Jun 12, 2026
- 4 Insider reported a trade Jun 12, 2026
- 4 Insider reported a trade Jun 12, 2026
Other 8 of 30
- EFFECT Notice that a registration became effective Mar 12, 2024
- CORRESP Reply to SEC staff Mar 8, 2024
- UPLOAD Comment letter from SEC staff Mar 8, 2024
- EFFECT Notice that a registration became effective Feb 9, 2023
- POSASR Feb 7, 2023
- EFFECT Notice that a registration became effective May 18, 2021
- EFFECT Notice that a registration became effective May 13, 2021
- CORRESP Reply to SEC staff May 11, 2021
Everything here comes from Praxis Precision Medicines, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.